May 18, 2017 / 6:44 AM / in 5 months

BRIEF-Neurovive Q1 pretax loss deepens

May 18 (Reuters) - Neurovive Pharmaceutical Ab

* Q1 net revenues were sek 27,000 (0) and other operating income was sek 63,000 (46,000)

* Q1 loss before tax was sek 21,390,000 (loss: 10,916,000) Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below